Quantcast

Latest Bicalutamide Stories

2015-05-17 12:23:02

TOKYO and SAN FRANCISCO, May 17, 2015 /PRNewswire/ -- Astellas Pharma Inc (TSE:4503) and Medivation, Inc (NASDAQ: MDVN) today announced data from the Phase 2 STRIVE trial comparing enzalutamide and

2015-04-02 08:28:58

TOKYO and SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc.

2015-03-24 08:32:43

TOKYO and SAN FRANCISCO, March 24, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.

2015-03-16 16:27:18

NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.

2013-03-18 20:42:21

Hormonal therapies can help control advanced prostate cancer for a time.

2013-02-11 15:53:09

While prostate cancer is the most common cancer in elderly Western men it also, but more rarely, strikes patients aged between 35 and 50.

2012-04-04 09:26:44

Patients with castration-resistant prostate cancer treated with the androgen inhibitor abiraterone and who had high baseline hormone levels had longer overall survival compared with patients with low hormone levels.

2012-03-28 08:33:49

Androgen suppression – the inhibition of testosterone and other male hormones – is a routine therapy for prostate cancer.

2012-02-01 10:22:54

A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show.

2011-06-22 16:12:52

Homosexual men taking bicalutamide for prostate cancer were much more likely to report sexual problems during treatment than heterosexual patients.


Word of the Day
meacock
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).